A contract research organization (CRO) is an organization that offers a wide range of pharmaceutical research services that include drug discovery, process development, toxicology, clinical trial management and many more services. NoAb BioDiscoveries is a leading ADME CRO that helps shape and optimize drug discovery research through a wide range of specialized and proprietary research services. Every pharmaceutical developer knows that pharmacokinetic studies on ADME (Absorption, Distribution, Metabolism and Excretion) are vital to identify viable drug candidates and to study how the body responds to them. As a leading ADME CRO, NoAb BioDiscoveries offers a number of in vivo pharmacokinetics studies, in vitro ADME assays, Bioanalysis and Gene Expression assays that offer its clients the ability to profile compounds for the selection of the best candidates for further pre-clinical and clinical development. These drug discovery services focus on lead selection and optimization through advanced research techniques that include innovative technologies and tools designed by the expert scientists at this exceptional research facility. These innovative technologies further accelerate the drug development process thereby reducing costs while enabling you to maximize profits.
The ADME CRO consists of experienced scientists who design the best strategies and protocols to suit any drug discovery need. These scientists skillfully design and perform standard and specialized PK studies according to clients' specifications. The studies are done in-house under strict guidelines by highly trained and experienced scientists guaranteeing you quality, efficient and timely service. PK studies typically involve the use of fully conscious animals that have been appropriately catheterized for drug administration and sample collection. Should you wish to examine the studies and study records at NoAb BioDiscoveries you are welcome to browse through the various case studies available at www.noabbiodiscoveries.com.
If you are a pharmaceutical developer looking to identify viable drug candidates in a short turnover time using studies on ADME, this CRO is the facility for you. The innovative tools are used to carry out PK studies in rats and mice and look at various aspects such as cell permeability, plasma protein binding, cytochrome P450 enzyme subtype inhibition, metabolic stability in hepatocytes and liver subcellular fractions, plasma stability, cytotoxicity and customer specific screening such as radiochemical and fluorescent assays. A comprehensive list of drug discovery services offered at the facility is available at www.noabbiodiscoveries.com. The facility is committed to providing accurate and reliable data using superior scientific procedures and continues to build the future of drug discovery research using innovation. NoAb BioDiscoveries is guaranteed to impress you as an ADME CRO that is dedicated to providing premier drug discovery services to its clients so that they can achieve success!
As an ADME CRO in constant pursuit of success through lead selection and optimization, NoAb BioDiscoveries offers high quality and high efficiency ADME profiling and toxicity evaluations to generate and prioritize leads for development into promising drug candidates. The research facility also uses DTEx™ technology which is a proprietary micro-array based technology to survey the effects of drug treatment on the expression level of genes involved in ADME pathways. This includes gene expression analysis of key phase I and phase II enzymes and phase III transporters. NoAb BioDiscoveries is an ADME CRO that is unparalleled in its ability to accelerate the drug discovery process in the industry, isn't it time you chose to be on the winning side of drug discovery research!
